Kanya Rajangam

NKTX

Kanya Rajangam serves as Pres. & Chief Med. & Dev. Off. at Nkarta, Inc. (NKTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$378.9K

Net Position

Net Seller

$378.9K

Companies Traded

SNTI, NKTX

Active Period

Aug 2021 – Feb 2025

2 total trades

Most Recent

Sell SNTI

Feb 6, 2025 · $6.1K

Kanya Rajangam's Insider Trading at Nkarta, Inc. (NKTX)

Buys

0 · $0.00

Sells

1 · $372.8K

Total Shares Bought

Total Shares Sold

10,000

NKTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 9, 2021↗	Sell	10,000	$37.28	$372.8K	0

Kanya Rajangam's Insider Trading at Senti Biosciences, Inc. (SNTI)

Buys

0 · $0.00

Sells

1 · $6.1K

Total Shares Bought

Total Shares Sold

1,479

SNTI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 6, 2025↗	Sell	1,479	$4.11	$6.1K	8,803

Related Insiders

Timothy K Lu

CEO

SNTISell · Feb 2, 2026

HASTINGS PAUL J

Chief Executive Officer

NKTXSell · Jan 15, 2026

HASTINGS PAUL J

director, officer: Chief Executive Officer

NKTXSell · Jan 15, 2026

Nadir Mahmood

officer: President

NKTXSell · Jan 15, 2026

Nadir Mahmood

President

NKTXSell · Jan 15, 2026

Explore More Insider Trading Data

NKTX Insider Trading Activity

View all insider trades at Nkarta, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity